WSK-V112

N/A

Report date: 2025/07/07 17:53:07

Base Information

Drug NameWSK-V112
Drug Alias NameRecombinant COVID-flu combination vaccineWSK-V112
ClassificationVaccines > Vaccine type > Combination vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesChengdu WestVac Biopharma Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesChengdu WestVac Biopharma Co Ltd
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A